JP2006124342A - Improving agent for fecal malodor - Google Patents

Improving agent for fecal malodor Download PDF

Info

Publication number
JP2006124342A
JP2006124342A JP2004316331A JP2004316331A JP2006124342A JP 2006124342 A JP2006124342 A JP 2006124342A JP 2004316331 A JP2004316331 A JP 2004316331A JP 2004316331 A JP2004316331 A JP 2004316331A JP 2006124342 A JP2006124342 A JP 2006124342A
Authority
JP
Japan
Prior art keywords
whey protein
improving agent
antibody
fecal
stool
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004316331A
Other languages
Japanese (ja)
Inventor
Mizuo Yajima
瑞夫 矢嶋
Satoshi Iwatsuki
聡 岩附
Hiroshi Shionoya
博 塩野谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asama Chemical Co Ltd
Original Assignee
Asama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asama Chemical Co Ltd filed Critical Asama Chemical Co Ltd
Priority to JP2004316331A priority Critical patent/JP2006124342A/en
Priority to CN2005800325638A priority patent/CN101052418B/en
Priority to EP05788363A priority patent/EP1795204A4/en
Priority to KR1020077001297A priority patent/KR101233648B1/en
Priority to EP09178187A priority patent/EP2177229A3/en
Priority to US11/663,248 priority patent/US20070207187A1/en
Priority to TW094133532A priority patent/TW200616546A/en
Priority to PCT/JP2005/018249 priority patent/WO2006035979A1/en
Publication of JP2006124342A publication Critical patent/JP2006124342A/en
Priority to HK08103552.6A priority patent/HK1113316A1/en
Pending legal-status Critical Current

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To obtain an improving agent for a fecal malodor comprising a whey protein as an active ingredient and having high deodorant effects. <P>SOLUTION: This improving agent for the fecal malodor comprises the whey protein and an antibody contained in the whey protein as an active ingredient. The improving agent for the fecal malodor preferably contains ≥0.5 mass% of the antibody of the whey protein and the improving effects on the fecal malodor become further remarkable when slightly digestible saccharides such as an oligosaccharide are further contained. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、乳清タンパクを有効成分として含有する、便臭改善剤に関する。   The present invention relates to a fecal odor improving agent containing whey protein as an active ingredient.

日本では高齢化社会を迎え、高齢者の介護は大変深刻な問題になっている。特に、寝たきりや自分で***行為のできない場合、おむつ交換やポータブルトイレ使用時に発生する臭いが室内に充満し、介護者ばかりでなく本人にとっても負担となっている。さらに、人工肛門を持つ人は、便臭の漏れが気になるために家にこもりがちになることが多くなるという問題があった。   In Japan, with the aging society, nursing care for the elderly has become a very serious problem. In particular, if you are bedridden or unable to excrete yourself, the smell generated when you change diapers or use a portable toilet fills the room, which is a burden not only for the caregiver but also for the person. Furthermore, there is a problem that people who have a colostomy tend to stay at home because they are concerned about the leakage of stool odor.

空気清浄器や消臭おむつ、消臭シーツ等の防臭対策用の介護用品も提供されているがこれらのものは便の臭いを根本的に絶つことはできない。   Nursing care products such as air purifiers, deodorant diapers, and deodorant sheets are also provided, but these cannot completely eliminate the smell of stool.

また、女性の間では、自分の体から発せられる臭気を無臭にしようとする風潮が高まっており、例えば、公衆トイレ、会社のトイレ等自宅以外のトイレで排便した場合に、この大便の臭いが該トイレに残留したり、また、衣服に残って一時的に体が臭うことを防止したいがために、排便を我慢してしまうことも少なくない。   In addition, there is an increasing trend among women to try to eliminate the odor emitted from their bodies. For example, the smell of this stool appears when you defecate in a toilet other than your home, such as a public toilet or a company toilet. There are many cases where the patient has to endure defecation in order to prevent the body from remaining in the toilet or from being temporarily smelled by being left in clothes.

このような糞便の悪臭成分は、メチルメルカプタン、アンモニア、硫化水素、インドール、スカトール、トリメチルアミンなどであり、クロストリジウム菌や大腸菌等のいわゆる悪玉菌と呼ばれる腸内細菌により産生される。   Such malodorous components of feces are methyl mercaptan, ammonia, hydrogen sulfide, indole, skatole, trimethylamine, and the like, and are produced by intestinal bacteria called so-called bad bacteria such as Clostridium bacteria and Escherichia coli.

このような糞便の悪臭を抑制するために、シャンピニオンエキスやカテキン、キトサン等様々な経口消臭剤が開発されているが、その消臭効果は充分満足できるものとはいえなかった。   Various oral deodorants such as champignon extract, catechin, and chitosan have been developed in order to suppress such stool malodor, but the deodorizing effect has not been sufficiently satisfactory.

本発明は、消臭効果の高い便臭改善剤を提供することを課題とする。   An object of the present invention is to provide a fecal odor improving agent having a high deodorizing effect.

本発明者らは、乳清タンパクの機能性について様々な角度から検討してきたところ、この乳清タンパクに便臭を著しく改善する作用があることを見出し、本発明に到達した。さらに精査したところ、乳清タンパク中に含まれる抗体が主たる有効成分であることがわかった。   The present inventors have studied the functionality of whey protein from various angles. As a result, they have found that this whey protein has an effect of remarkably improving the stool odor, and reached the present invention. Further examination revealed that antibodies contained in whey protein were the main active ingredients.

すなわち、本発明は下記のとおりである。
1)乳清タンパクを含有することを特徴とする便臭改善剤、
2)乳清タンパク中の抗体を有効成分とする前記1)に記載の便臭改善剤、
3)抗体が0.5質量%以上含まれる請求項1または2に記載の便臭改善剤、
4)難消化性糖類をさらに含有する請求項1〜3のいずれか1項に記載の便臭改善剤。
That is, the present invention is as follows.
1) A fecal odor improving agent characterized by containing whey protein,
2) The fecal odor improving agent according to 1) above, which comprises an antibody in whey protein as an active ingredient,
3) The stool improving agent according to claim 1 or 2, wherein the antibody is contained in an amount of 0.5% by mass or more,
4) The stool odor improving agent according to any one of claims 1 to 3, further comprising an indigestible saccharide.

本発明によれば、乳清タンパク中の抗体を有効成分として用いることにより、優れた便臭改善剤を提供することができる。抗体含量が0.5質量%以上であるとその改善効果が顕著になり、難消化性糖類をさらに配合するとさらにその改善効果が大となる。   According to the present invention, an excellent stool odor improving agent can be provided by using an antibody in whey protein as an active ingredient. When the antibody content is 0.5% by mass or more, the improvement effect becomes remarkable, and when the indigestible saccharide is further added, the improvement effect is further increased.

本発明において、乳清タンパクは通常の市販されているもの、すなわち、ホエータンパク濃縮物(WPC)、ホエータンパク単離物(WPI)、脱塩ホエー粉等が使用できるが、抗体含有量の高いもののほうが好ましい。乳清からの乳清タンパクの分離法についても、マイクロフィルタレーション法、クロスフローマイクロフィルタレーション法、イオン交換法、その他いずれの方法によるものでも使用できる。   In the present invention, whey protein may be a normal commercially available product, that is, whey protein concentrate (WPC), whey protein isolate (WPI), desalted whey powder, etc., which have a high antibody content. Things are preferred. As a method for separating whey protein from whey, any of the microfiltration method, the cross-flow microfiltration method, the ion exchange method, and the like can be used.

本発明において用いる乳清タンパクの原料となる乳は牛、ヤギ、ヒツジ、馬、水牛等いずれの哺乳動物の乳でもよい。また、その乳はワクチン接種を受けた哺乳動物から採取された乳でも、ワクチン接種を受けていない哺乳動物から採取された乳でもよい。   Milk used as a raw material for whey protein used in the present invention may be milk of any mammal such as cow, goat, sheep, horse, buffalo and the like. The milk may be milk collected from a mammal that has been vaccinated or milk collected from a mammal that has not been vaccinated.

一般に、乳清タンパクはハム、ソーセージ等の物性改良や、製パン、ヨーグルト等の品質改良に利用されてきており、最近ではそのアミノ酸の配列が人乳に近く栄養価に富み、必須アミノ酸をすべて含み、吸収率が非常によく、また、分岐鎖アミノ酸の含有率も高いことから、タンパク質を補給するための栄養補助食品として、主にスポーツ選手や運動負荷の高い人向けの商品に利用されているものである。   In general, whey protein has been used to improve the physical properties of ham, sausage, etc., and to improve the quality of bread making, yogurt, etc. Recently, its amino acid sequence is close to that of human milk and is rich in nutritional value. Because it has a very good absorption rate and a high content of branched chain amino acids, it is mainly used as a dietary supplement for protein supplements in products for athletes and people with high exercise load. It is what.

乳清タンパクには、原料の生乳に由来する抗体が残存しているものもある。本発明の便臭改善効果は、このような乳清タンパクに含まれる抗体により奏される作用である。したがって、本発明の便臭改善剤には乳清タンパクの抗体が0.5質量%以上含まれていることが便臭改善のためには望ましい。また、成人においては、乳清タンパクの抗体を一日あたり50mg以上摂取すると便臭改善のために効果的である。   Some whey proteins retain antibodies derived from raw raw milk. The fecal odor improving effect of the present invention is an effect exhibited by the antibody contained in such whey protein. Therefore, the stool odor improving agent of the present invention preferably contains 0.5% by mass or more of whey protein antibody in order to improve stool odor. In adults, taking 50 mg or more of whey protein antibody per day is effective in improving stool odor.

また、本発明の便臭改善には、難消化性糖類を配合するとさらにその効果が顕著となる。難消化性糖類としては、食品として使用できる難消化性糖類であれば、いずれの糖類も用いることができる。例えば、フラクトオリゴ糖、乳果オリゴ糖(ラクトスクロース)、ラクチュロース、イソマルトオリゴ糖、大豆オリゴ糖、ガラクトオリゴ糖、大豆オリゴ糖、キシロオリゴ糖、ラフィノース、パラチノースオリゴ糖、ニゲロオリゴ糖、ゲンチオオリゴ糖、トレハロース、カップリングシュガー、ペクチンオリゴ、シクロデキストリン等のオリゴ糖;ソルビトール、マルチトール、エリスリトール、還元パラチノース、ラクチトール、マンニトール、キシリトール等の糖アルコール;イヌリン;難消化性デキストリン;レジスタントスターチ等を挙げることができる。これらの糖質は通常の市販されているものを用いることができる。本発明において難消化性糖類とは、体内の消化酵素で消化されにくい糖類をいうので、脂溶性の物質や、ゼイン、グリアジン等のプロミランで被覆された易消化性糖類も、ここでいう難消化性糖類として用いることができる。難消化性糖類は乳清タンパク100質量部に対し、5〜1000質量部添加することが好ましい。   In addition, the effect of the present invention is more remarkable when a less digestible saccharide is added to the stool odor improvement of the present invention. As the indigestible saccharide, any saccharide can be used as long as it is an indigestible saccharide that can be used as food. For example, fructooligosaccharides, dairy oligosaccharides (lactosucrose), lactulose, isomalto-oligosaccharides, soybean oligosaccharides, galacto-oligosaccharides, soybean oligosaccharides, xylo-oligosaccharides, raffinose, palatinose oligosaccharides, nigerooligosaccharides, gentio-oligosaccharides, trehalose, coupling Examples include oligosaccharides such as sugar, pectin oligo, and cyclodextrin; sugar alcohols such as sorbitol, maltitol, erythritol, reduced palatinose, lactitol, mannitol, and xylitol; inulin; indigestible dextrin; These carbohydrates can be those that are usually commercially available. In the present invention, the indigestible saccharide refers to a saccharide that is difficult to be digested by digestive enzymes in the body. Therefore, an easily digestible saccharide coated with a fat-soluble substance or promilan such as zein or gliadin is also referred to herein as indigestible. It can be used as a sex sugar. The indigestible saccharide is preferably added in an amount of 5 to 1000 parts by mass per 100 parts by mass of whey protein.

難消化性糖類は腸内ビフィズス菌の増殖因子となり、また、整腸作用もある。乳清タンパクと難消化性糖類を同時に摂取すると、両者の相乗的作用でさらに便臭改善効果が顕著となる。   Indigestible saccharides are growth factors for intestinal bifidobacteria and also have an intestinal regulating action. When whey protein and indigestible saccharides are ingested at the same time, the fecal odor improving effect becomes more remarkable due to the synergistic action of both.

本発明の便臭改善剤は、有効成分としての乳清タンパクのほかに、賦形剤、甘味料、酸味料、香料、乳化剤、増粘多糖類、着色料等の通常、食品に添加される食品添加物原料を含有することができる。   The stool odor improving agent of the present invention is usually added to foods such as excipients, sweeteners, acidulants, fragrances, emulsifiers, thickening polysaccharides and coloring agents in addition to whey protein as an active ingredient. A food additive raw material can be contained.

本発明において、便臭改善剤の形態は限定されない。例えば、錠剤、粉末、顆粒、カプセル剤でもよいし、ペースト状、液状でもよい。乳清タンパク添加後に抗体が失活するような加熱加工工程がなければ、加工食品の形態をとることもできる。   In the present invention, the form of the fecal odor improving agent is not limited. For example, it may be a tablet, powder, granule, capsule, paste, or liquid. If there is no heat processing step that inactivates the antibody after addition of whey protein, it can take the form of processed food.

[実施例]
以下に実施例を挙げて本発明をさらに具体的に説明するが、本発明はそれらに限定されるものではない。
[Example]
EXAMPLES The present invention will be described more specifically with reference to examples below, but the present invention is not limited thereto.

[実施例1]
乳清タンパクであるミラクテール80(森永乳業(株)製)を、ショ糖とCMC(カルボキシメチルセルロース)の等量混合物で10倍散にして、流動層造粒機で品温が65℃達温になるように調製しながら顆粒状とし、便臭改善剤として、以下の効果の試験に用いた。この顆粒の抗体含有量は0.5質量%であった。
[Example 1]
Milactail 80 (manufactured by Morinaga Milk Industry Co., Ltd.), a whey protein, was dispersed 10 times with an equal mixture of sucrose and CMC (carboxymethylcellulose), and the product temperature reached 65 ° C with a fluid bed granulator. While being prepared, it was granulated and used as a stool odor improving agent for the following effects test. The antibody content of the granules was 0.5% by mass.

(効果の試験)
被験者として、男女20名(21〜30歳:12名、31〜40歳:4名、41〜60歳:4名)を4つの群(各群5名)に分け、試験群1には実施例1で得られた顆粒(便臭改善剤)を5g(抗体として25mg)、試験群2には10g(抗体として50mg)、試験群3には20g(抗体として100mg)を100mlの水に懸濁させ、毎朝食後に飲用してもらった。また、対照群として毎朝食後にショ糖とCMCの等割(質量)粉末10gを100mlの水に懸濁させて飲用してもらった。
(Effectiveness test)
As test subjects, 20 men and women (21-30 years old: 12 people, 31-40 years old: 4 people, 41-60 years old: 4 people) are divided into 4 groups (5 people in each group). 5 g (25 mg as an antibody) of the granule obtained in Example 1 (25 mg as an antibody), 10 g (50 mg as an antibody) in Test Group 2, and 20 g (100 mg as an antibody) in Test Group 3 in 100 ml of water. It was turbid and taken after every breakfast. In addition, as a control group, 10 g of sucrose and CMC equally divided (mass) powder were suspended in 100 ml of water after breakfast and were drunk.

そして、飲用前、飲用開始3日後、7日後の便臭について、5段階(0:ほとんど気にならない、1:わずかに臭い、2:普通、3:臭い、4:ひどく臭い)で官能評価してもらい、その平均値を求めた。その結果を表1に示す。   The fecal odor before drinking, 3 days after drinking, and 7 days after drinking, was sensory-evaluated in 5 stages (0: hardly noticed, 1: slightly smelled, 2: normal, 3: smell, 4: bad smell) The average value was obtained. The results are shown in Table 1.

(表1)
飲用前 3日後 7日後
試験群1(抗体として25mg) 2.8 2.2 1.8
試験群2(抗体として50mg) 2.6 1.4 0.6
試験群3(抗体として100mg) 2.8 1.0 0.4
対照群 2.6 2.8 2.6
(Table 1)
Before drinking 3 days later 7 days later Test group 1 (25 mg as antibody) 2.8 2.2 1.8
Test group 2 (50 mg as antibody) 2.6 1.4 0.6
Test group 3 (100 mg as antibody) 2.8 1.0 0.4
Control group 2.6 2.8 2.6

表1から各試験群は便臭が改善されていることがわかる。特に試験群2、試験群3は便臭の改善効果が顕著であることがわかる。なお、試験期間中、試験群の被験者の多くにおいておならの臭いも改善され、また、便通の改善もみられた。   From Table 1, it can be seen that each test group has improved stool odor. In particular, it can be seen that Test Group 2 and Test Group 3 have a remarkable effect of improving stool odor. During the test period, the fart odor was improved in many of the subjects in the test group, and the bowel movement was also improved.

[実施例2]
乳清タンパクであるミラクテール80(森永乳業(株)製)8質量部とフラクトオリゴ糖であるメイオリゴCR(明治製菓(株)製)2質量部を混合し、流動層造粒機で品温が65℃達温になるように調製しながら顆粒状とし、便臭改善剤として、以下の効果の試験に用いた。この顆粒の抗体含有量は4.0%であった。
[Example 2]
Mixing 8 parts by weight of wilted protein Miractail 80 (manufactured by Morinaga Milk Industry Co., Ltd.) and 2 parts by weight of fructooligosaccharide Meioligo CR (manufactured by Meiji Seika Co., Ltd.), the product temperature is 65 in a fluid bed granulator. It was granulated while preparing to reach a temperature of 0 ° C., and used as a stool odor improving agent for the following effects test. The antibody content of the granules was 4.0%.

(効果の試験)
被験者として、特に便臭の臭いが強くて気になるという男性4名(61〜67歳)を選び、試験群4として、実施例2で得られた顆粒(便臭改善剤)を5g(抗体として200mg)を100mlの水に懸濁させ、毎朝食後に飲用してもらった。そして、飲用前、飲用開始3日後、7日後の便臭について、実施例1の効果の試験と同様に5段階で官能評価した。その平均値を表2に、個人の評価点をグラフにしたものを図1に示す。
(Effectiveness test)
As subjects, 4 males (61-67 years old) who are particularly worried about the smell of fecal odors were selected. As test group 4, 5 g of the granules (fecal odor improving agent) obtained in Example 2 (antibody) 200 mg) was suspended in 100 ml of water and taken after breakfast. The fecal odor before drinking, 3 days after starting drinking, and 7 days after drinking was subjected to sensory evaluation in five stages in the same manner as the test of the effect of Example 1. The average values are shown in Table 2, and the individual evaluation points are shown in a graph in FIG.

(表2)
飲用前 3日後 7日後
試験群4(抗体として200mg) 4.0 2.25 1.25
(Table 2)
Before drinking 3 days later 7 days later
Test group 4 (200 mg as antibody) 4.0 2.25 1.25

表2および図1を表1と対比するとわかるように、便臭の臭いが強くて気になるという人のほうが、便臭改善の効果が高い。特に、このうちの1名は抗体200mgを7日間服用することによって、便臭がひどく臭いレベル(4)からほとんど気にならないレベル(0)にまで改善された。   As can be seen by comparing Table 2 and FIG. 1 with Table 1, the person who is concerned about the smell of stool is more effective in improving stool odor. In particular, in one of them, taking 200 mg of antibody for 7 days improved the stool odor from a severely odorous level (4) to a level (0) that was hardly noticed.

実施例2の効果の試験における官能評価の評価点を個人別に示したグラフである。5 is a graph showing sensory evaluation scores for each individual in the effect test of Example 2. FIG.

Claims (4)

乳清タンパクを含有することを特徴とする便臭改善剤。 A fecal odor improving agent characterized by containing whey protein. 乳清タンパク中の抗体を有効成分とする請求項1に記載の便臭改善剤。 The stool odor improving agent according to claim 1, comprising an antibody in whey protein as an active ingredient. 抗体が0.5質量%以上含まれる請求項1または2に記載の便臭改善剤。 The stool odor improving agent according to claim 1 or 2, wherein the antibody is contained in an amount of 0.5 mass% or more. 難消化性糖類をさらに含有する請求項1〜3のいずれか1項に記載の便臭改善剤。

The stool odor improving agent according to any one of claims 1 to 3, further comprising an indigestible saccharide.

JP2004316331A 2004-09-29 2004-10-29 Improving agent for fecal malodor Pending JP2006124342A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2004316331A JP2006124342A (en) 2004-10-29 2004-10-29 Improving agent for fecal malodor
CN2005800325638A CN101052418B (en) 2004-09-29 2005-09-27 Use of bacterial endotoxin antibody in preparing medicine for treating rheumatoid arthritis
EP05788363A EP1795204A4 (en) 2004-09-29 2005-09-27 Functional composition or food containing whey protein, antibody derived from milk, or antibody
KR1020077001297A KR101233648B1 (en) 2004-09-29 2005-09-27 Functional composition or food containing whey protein, antibody derived from milk, or antibody
EP09178187A EP2177229A3 (en) 2004-09-29 2005-09-27 Functional composition or food comprising whey protein, antibody derived from milk or antibody
US11/663,248 US20070207187A1 (en) 2004-09-29 2005-09-27 Functional Composition Or Food Comprising Whey Protein, Antibody Derived From Milk Or Antibody
TW094133532A TW200616546A (en) 2004-09-29 2005-09-27 A function composition or food containing a whey protein, an antibody from milk or an antibody
PCT/JP2005/018249 WO2006035979A1 (en) 2004-09-29 2005-09-27 Functional composition or food containing whey protein, antibody derived from milk, or antibody
HK08103552.6A HK1113316A1 (en) 2004-09-29 2008-03-31 Functional composition or food containing lactalbumin, antibody and antibody fragment derived from milk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004316331A JP2006124342A (en) 2004-10-29 2004-10-29 Improving agent for fecal malodor

Publications (1)

Publication Number Publication Date
JP2006124342A true JP2006124342A (en) 2006-05-18

Family

ID=36719414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004316331A Pending JP2006124342A (en) 2004-09-29 2004-10-29 Improving agent for fecal malodor

Country Status (1)

Country Link
JP (1) JP2006124342A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007330193A (en) * 2006-06-16 2007-12-27 Asama Chemical Co Ltd Food having new function, and method for producing the same
JP2008022704A (en) * 2006-06-20 2008-02-07 Asama Chemical Co Ltd Food additive composition for preventing infectious disease
WO2009072674A1 (en) * 2007-12-07 2009-06-11 Fujifilm Corporation Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
WO2023038153A1 (en) 2021-09-13 2023-03-16 Spiber株式会社 Deodorant material, agent for imparting deodorant properties, and method for imparting deodorant properties

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007330193A (en) * 2006-06-16 2007-12-27 Asama Chemical Co Ltd Food having new function, and method for producing the same
JP2008022704A (en) * 2006-06-20 2008-02-07 Asama Chemical Co Ltd Food additive composition for preventing infectious disease
WO2009072674A1 (en) * 2007-12-07 2009-06-11 Fujifilm Corporation Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
WO2023038153A1 (en) 2021-09-13 2023-03-16 Spiber株式会社 Deodorant material, agent for imparting deodorant properties, and method for imparting deodorant properties

Similar Documents

Publication Publication Date Title
JP4911700B2 (en) Antibacterial composition
RU2012117804A (en) BIFIDOBACTERIUM LONGUM ATCC BAA-999 (BL999) AND WEIGHT CONTROL
BRPI1010617B1 (en) use of a composition, composition, and method for preparing a composition
KR102548553B1 (en) Bifidobacterium for increasing lean body mass
EP1162987A1 (en) Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
WO2016121923A1 (en) Muscle synthesis promoter
US20040077539A1 (en) $g(a)-lactalbumin as prebiotic agent
RU2018127650A (en) Fermented milk mixture with indigestible oligosaccharides
JP2007001900A (en) Tryptophanase inhibitor and composition containing the inhibitor
RU2343724C1 (en) Method of manufacturing biologically active products from brown algae
JP4452569B2 (en) Foods based on peach blossoms and lactoferrin
JP2006124342A (en) Improving agent for fecal malodor
JPWO2009057287A1 (en) Food material for inhibiting osteoclast formation
JP2006325447A (en) Anti-helicobacter pylori food and drink
KR102182093B1 (en) Oral composition comprising graviola mixed powder easy to take
JP4630161B2 (en) Whey protein food with intestinal regulation
JP2009526748A (en) Calcium absorption promoter
JP2006160697A (en) Sleep-related health ameliorative agent
JP6430386B2 (en) Body moisture retention agent
JP2006271267A (en) Dietary supplement having deodorant function
JP2007053930A (en) Method for producing antibody-containing fermented food
TWI530256B (en) Method for producing anti-mental fatigue agent utilizing ferro-bound lactoferrin
JP6961569B2 (en) Hydration agent
JP4351815B2 (en) Diet food
JP2007185134A (en) Packaged beverage and method for producing the same

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20070626